HBA Seattle Announces New Advisory Board

HBA Seattle is pleased to announce our Seattle-area advisory board, serving the HBA Pacific region:


Dr. Toni Hoover
, director for strategy, planning, and management, global health division, The Gates Foundation:
Toni Hoover leads a team at the Bill and Melinda Gates Foundation that is working to create more opportunities to consistently deliver high impact interventions in global health. She also oversees the foundation’s fellows program.
Before joining the foundation in 2012, Dr. Hoover was senior vice president and site director at Pfizer Worldwide Research and Development, overseeing the operations of the company’s largest R&D laboratories located in Groton, Connecticut. She is a 25-year veteran of pharmaceutical R&D product development and management, having held positions in clinical research and operations, project and portfolio management, and laboratory and facilities management. While at Pfizer she led the global development of Lyrica® from exploratory development through early commercialization. Dr. Hoover received her bachelor of arts, masters, and doctorate in psychology and social relations from Harvard University. She serves on several not-for-profit boards, including University of Washington Medicine, New York Academy of Sciences, Xavier University of Louisiana, the Joyce Theater, and the Pacific Northwest Ballet.


Brad Gray
, president and CEO, Nanostring Technologies:
R. Bradley Gray has served as a member of the board of directors and as president and chief executive officer since June 2010. Prior to joining Nanostring, Mr. Gray held various positions at Genzyme, a biotechnology company acquired by Sanofi in 2011. Prior to joining Genzyme, Mr. Gray was a management consultant in the healthcare practice of McKinsey & Company, a global management consulting firm, from September 2000 to October 2004, where he worked with senior healthcare executives in the United States and Europe on a broad range of issues including pharmaceutical and diagnostic product strategy, post-merger integration, organization design, and operational turnarounds. Mr. Gray received a B.A. in economics and management from Oxford University, where he studied as a British Marshall Scholar, and an S.B. in chemical engineering from the Massachusetts Institute of Technology.


Cheryl Lubbert
, president and CEO, Health Perspectives Group
Ms. Lubbert is president and CEO of Health Perspectives Group (HPG), parent company to Health Advocacy Strategies, Patient Health Perspectives and Health Stories Project. A 25-year veteran of general management and commercial development experience with Fortune 500 companies, Cheryl has led blockbuster launches and commercialization efforts. Prior to the founding of Health Perspectives Group, Ms. Lubbert was the divisional vice president for the $3 billion Abbott Labs Immunology franchise that included responsibility for all HUMIRA commercial efforts in rheumatology, dermatology, gastroenterology and institutions. Additionally, she has held positions in management, marketing, research, sales, managed care and sales training at Bristol-Myers Squibb, Immunex, Inc., and Amgen, launching and building brands in the diabetes and autoimmune markets including Glucophage®, Glucovance®, Glucophage® XR and Enbrel®. Lubbert also served as president of a venture capital-backed marketing services roll-up focused on healthcare market research, physician education and patient engagement. Ms. Lubbert holds a B.S. in microbiology at the University of Maryland, and is also the founder and co-owner of Nashi Orchards Cidery, on beautiful Vashon Island in the heart of Puget Sound.